-
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary RevascularizationH Kawashima , PW Serruys, and on behalf of the SYNTAX Extended Survival Investigators et al. -
Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery OcclusionsH Kawashima , K Takahashi , the SYNTAX Extended Survival Investigators et al.
-
Transcatheter Mitral-Valve Repair in Patients with Heart FailureStone GW, Lindenfeld J, COAPT Investigators et al.
-
State of the Art in Noninvasive Imaging of Ischemic Heart Disease and Coronary Microvascular Dysfunction in Women: Indications, Performance, and LimitationsP Koilpillai, NR Aggarwal, SL Mulvagh et al.
-
Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial InfarctionJC Choe, KS Cha, Korea Acute Myocardial Infarction Registry-National Institutes of Health Investigators et al.
-
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialRidker PM, MacFadyen JG, CANTOS Trial Group et al.
-
Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyMcNeil JJ, Nelson MR, ASPREE Investigator Group.
-
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart AssociationBenjamin EJ, Muntner P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
